the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

BAM: Tze Yong sustained injury to his spine

KUALA LUMPUR: National men’s singles shuttler Ng Tze Yong (pix) injured his spine when fielded in the recent Badminton Asia Team Championships 2024, said Badminton Association of Malaysia (BAM) Sports Medicine head Ooi Yu Hang.

She emphasised that it was not a recurrence of the injury he sustained at the 2024 Malaysia Open where the world number 15 suffered muscle tear in the lower back.

Yu Hang said they are monitoring Tze Yong’s reaction to the jabs given by the National Sports Institute (NSI) last week.

“It’s a different kind of injury (from the one he suffered at the Malaysian Open). The tear from the Malaysia Open is already healed. (This time) it’s related to his spine and disc. Tze Yong had the injections after last week.

“So we need to monitor (him) as suggested by the doctor from the NSI to see how he responds towards the injections in these 10 days. So, during these 10 days, we will allow Tze Yong to do some light training but the main focus will be rehabilitation (at the ABM) to strengthen the muscles,” she told reporters at Akademi Badminton Malaysia (ABM) in Bukit Kiara here today.

Tze Yong, who was fielded in the BATC 2024 quarter-final clash against Singapore’s Jason Teh at the Setia City Convention Centre in Shah Alam on Friday (Feb 16), lasted just three minutes before retiring while trailing 1-3 in the first game. -Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings